It has also been reported that NGR modification of antiangiogenic molecules, such as endostatin, could improve tumor localization and, in consequence, effectively inhibited ovarian carcinoma growth in athymic nude mice [11], indicating that addition of a vascular targeting sequence NGR could enhance the biological activity of an antitumor or antiangiogenic molecule. The gene discussed is RTN4R; the disease is neoplasm.